Fabtech Technologies Cleanrooms Ltd
Incorporated in 2015, Fabtech Technologies Cleanrooms Limited is a global company specializing in turnkey engineering solutions for the pharmaceutical, biotech, and healthcare sectors.[1]
- Market Cap ₹ 375 Cr.
- Current Price ₹ 305
- High / Low ₹ 342 / 162
- Stock P/E 64.9
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 15.7 %
- ROE 11.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding has decreased over last quarter: -24.7%
- Company has a low return on equity of 13.7% over last 3 years.
- Company has high debtors of 193 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 89.29 | 70.23 | 113.70 | 124.67 | 97.39 | |
| 83.30 | 68.78 | 107.45 | 111.83 | 88.84 | |
| Operating Profit | 5.99 | 1.45 | 6.25 | 12.84 | 8.55 |
| OPM % | 6.71% | 2.06% | 5.50% | 10.30% | 8.78% |
| 0.78 | 0.26 | 0.25 | 0.44 | 0.60 | |
| Interest | 0.58 | 0.36 | 0.76 | 1.20 | 1.12 |
| Depreciation | 0.68 | 0.82 | 0.58 | 0.53 | 0.50 |
| Profit before tax | 5.51 | 0.53 | 5.16 | 11.55 | 7.53 |
| Tax % | 28.49% | -41.51% | 32.95% | 30.65% | 24.97% |
| 4.00 | 0.76 | 3.46 | 8.01 | 5.82 | |
| EPS in Rs | 1,333.33 | 250.00 | 12.24 | 28.57 | 20.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 12% |
| TTM: | -22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 98% |
| TTM: | -27% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 14% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.03 | 0.03 | 2.79 | 2.79 | 2.79 | 9.06 |
| Reserves | 30.88 | 31.63 | 35.04 | 42.75 | 48.86 | 53.00 |
| 10.24 | 7.14 | 8.50 | 5.66 | 5.75 | 3.20 | |
| 26.06 | 30.25 | 35.79 | 29.37 | 31.71 | 29.13 | |
| Total Liabilities | 67.21 | 69.05 | 82.12 | 80.57 | 89.11 | 94.39 |
| 4.20 | 4.70 | 4.38 | 4.07 | 5.11 | 4.99 | |
| CWIP | 0.00 | 0.00 | 0.13 | 0.00 | 0.00 | 0.00 |
| Investments | 0.39 | 0.39 | 0.40 | 0.05 | 1.05 | 8.60 |
| 62.62 | 63.96 | 77.21 | 76.45 | 82.95 | 80.80 | |
| Total Assets | 67.21 | 69.05 | 82.12 | 80.57 | 89.11 | 94.39 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| -8.68 | 3.88 | 3.25 | 7.98 | 2.76 | |
| 2.49 | -0.92 | -4.11 | -3.14 | -1.52 | |
| 7.40 | -3.38 | 0.74 | -3.96 | -0.94 | |
| Net Cash Flow | 1.21 | -0.42 | -0.12 | 0.87 | 0.31 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 181.05 | 221.19 | 165.29 | 143.72 | 193.39 |
| Inventory Days | 62.64 | 94.58 | 62.71 | 56.89 | 87.75 |
| Days Payable | 114.14 | 146.09 | 103.47 | 81.58 | 121.65 |
| Cash Conversion Cycle | 129.55 | 169.68 | 124.53 | 119.04 | 159.48 |
| Working Capital Days | 154.27 | 178.89 | 118.97 | 111.31 | 156.43 |
| ROCE % | 2.15% | 13.74% | 25.84% | 15.74% |
Documents
Announcements
-
Outcome Of The Analyst / Investor Meeting Held On February 18, 2025
18 Feb - Outcome of Analyst/Investor Meeting held on February 18, 2025.
- Announcement under Regulation 30 (LODR)-Investor Presentation 17 Feb
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12 Feb - Of Schedule of Analyst/Investor Meeting under the SEBI (LODR) Regulations 2015
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
20 Jan - Compliance certificate under SEBI regulations for Q4 2024.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
20 Jan - Compliance certificate under SEBI regulations for Q4 2024.
Annual reports
No data available.
Concalls
-
Feb 2025TranscriptNotesPPT
Business Overview[1]
Fabtech Technologies Cleanrooms specializes in manufacturing and providing end-to-end solutions for pre-engineered and pre-fabricated modular panels and doors for cleanrooms. These cleanrooms are used in pharmaceutical, healthcare, and biotech sectors and adhere to global regulatory standards like ISO and FDA. The company offers services including design, engineering, manufacturing, quality assurance, installation, and validation.